Clinical Evaluation of PROMIS in CKD

CompletedOBSERVATIONAL
Enrollment

213

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

August 30, 2020

Study Completion Date

August 30, 2020

Conditions
Chronic Kidney Diseases
Trial Locations (16)

19104

Children's Hospital of Philadelphia, Philadelphia

21287

Johns Hopkins Children's Center, Baltimore

28203

Levine Children's, Charlotte

30322

Children's Healthcare of Atlanta, Atlanta

35205

Children's Hospital of Alabama, Birmingham

43205

Nationwide Children's Hopsital, Columbus

44195

Cleveland Clinic, Cleveland

45229

Cincinnati Children's Hospital and Medical Center, Cincinnati

46202

Riley Hospital for Children, Indianapolis

48109

University of Michigan, Mott Hospital, Ann Arbor

63110

St. Louis Children's Hospital, St Louis

64108

Children's Mercy Hospital, Kansas City

90095

UCLA, Los Angeles

97201

Oregon Health and Science University, Portland

98105

Seattle Children's Hospital, Seattle

MB R3E 3P4

Children's Hospital Research Institute of Manitoba, Winnipeg

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Children's Hospital of Philadelphia

OTHER

NCT03842293 - Clinical Evaluation of PROMIS in CKD | Biotech Hunter | Biotech Hunter